The Alliance for Multispecialty Research (AMR) is an industry-leading clinical research company comprising 17 of the most highly experienced clinical research centers in the United States. Founded in 1994, AMR centers have enrolled over 145,000 subjects and completed more than 7,700 Phase I-IV clinical trials across a broad range of therapeutic areas, including studies evaluating pharmacokinetics, pharmacodynamics, and bioequivalent/bioavailability.
AMR has access to over 657,000 patients, allowing us to perform detailed searches to promptly identify prospective subjects. Our proven experience, streamlined processes, and vast resources empower us to consistently meet or exceed study enrollment targets. We employ intentional strategies designed to optimize enrollment and retention, resulting in an average enrollment rate of more than 110%, and an average retention rate of more than 92% across all therapeutic areas.
Vaccine ExperienceFrom preventive, to bioterrorism and therapeutic vaccines, AMR centers have mastered the art of vaccine research. Stellar performance in vaccine clinical trials has earned AMR a reputation of excellence across the industry. AMR is a three-time recipient of the World Vaccine Congress’s Vaccine Industry Excellence (ViE) Award for “Best Clinical Trial Site or Network” (2013, 2015, 2017) and was a finalist for this prestigious award in 2018. Vaccine clinical experience includes:
Therapeutic ExperienceHistorically, AMR clinical research centers have enrolled more than 145,000 subjects in 7,749 clinical trials. AMR’s extensive experience includes Phase I-IV healthy volunteer trials, device trials, and disease-specific trials across a wide range of therapeutic areas. The following list summarizes AMR’s primary areas of expertise:
AMR centers offer responsive solutions, intentionally designed for each unique project. Our flexible model allows clients to custom-design a project management plan that works best for their trial.
Integrated Solution: Sponsors and CROs can choose from a centralized option, maximizing efficiencies using a central point of contact and standardized documents.
Direct-to-Center Solution: Clients can elect a direct-to-site approach, capitalizing on existing deep relationships with our local centers and investigators.